Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer's Shares Rise on Strong Q1 Results

NEW YORK (GenomeWeb News) – Shares of PerkinElmer climbed just above 15 percent in afternoon trading on the New York Stock Exchange following its announcement after the close of the market yesterday of strong first-quarter results.
 
PerkinElmer’s shares climbed as high as 20 percent to $27.25 during the trading session before settling back to $26.18 in the afternoon.
 
The firm reported revenues of $511.5 million for the quarter ended Dec. 30, 2007 — a 20 percent gain on its fourth-quarter revenues the year before. PerkinElmer also said that its quarterly profit jumped 26 percent to $52.6 million, or $.44 per share, which beat Wall Street estimates.
 
The firm’s shares rose after a couple of analysts published positive research notes on PerkinElmer, citing potential revenue growth from new products and acquisitions. The company recently spent around $300 million to acquire ViaCell, a Cambridge, Mass.-based specialty stem cell company.
 
PerkinElmer officials predicted during an October conference call that with the acquisition of ViaCell, the firm would grow its genetic screening revenue to around $500 million by 2010, up from roughly $270 million from the combined businesses of PerkinElmer and ViaCell in 2007.
 
Last month, PerkinElmer said it would buy Pediatrix Medical’s newborn metabolic screening business for an undisclosed amount.
 
 
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.